Clinical Trial Update: Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

View source ↗

Summary

This clinical trial update reports a real-life assessment of Abilify Maintena (aripiprazole long-acting injectable) plus Rexulti (brexpiprazole) in schizophreni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ABILIFY MAINTENA (ARIPIPRAZOLE)
• REXULTI (brexpiprazole)

Snippet

Sponsor: The University of Hong Kong | Conditions: Schizophrenia and Related Disorders, Anxiety Depression | Status: RECRUITING